ALS Investment Fund
Venture Capital
Venture capital fund investing in biotech companies developing therapies for neurodegeneration, focusing on ALS.
Early Stage
Biotech
Neurodegeneration
- Headquarters
- Amsterdam, Netherlands
- Founded
- 2016
- Website
- alsinvestmentfund.com
- AUM
- $70
- Last Investment
- Nov 2023
- Geographic Focus
- Global
Investment Thesis
Backs biotech innovators advancing treatments for ALS and other neurodegenerative diseases to improve patient outcomes.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account